December 3, 2013—The AIDS Healthcare Foundation (AHF) has filed a third lawsuit—this time, against drug manufacturer AbbVie and its progenitor company Abbott—alleging it was overcharged for HIV/AIDS drugs subject to 340B drug discounts. Abbott and AbbVie became separate companies in January 2013.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)